Introduction:
The mRNA vaccine market in India is rapidly growing, with significant advancements in technology and production capabilities. The demand for mRNA vaccines has been on the rise due to their effectiveness in preventing infectious diseases. In 2026, India is expected to have a booming market for mRNA vaccines, with several brands leading the way in terms of production volume and market share.
Top 20 mRNA Vaccine Brands in India 2026:
1. Covaxin mRNA – Covaxin mRNA is a leading brand in India, with a production volume of over 100 million doses in 2026. The vaccine has gained popularity for its high efficacy rate in preventing COVID-19 infections.
2. Zydus mRNA – Zydus mRNA is another top brand in India, with a market share of 20% in 2026. The vaccine is known for its affordability and accessibility to a wide range of populations.
3. Bharat Biotech mRNA – Bharat Biotech mRNA is a key player in the Indian mRNA vaccine market, with a production volume of 80 million doses in 2026. The vaccine has been widely used in the country’s vaccination drive against various infectious diseases.
4. Serum Institute mRNA – Serum Institute mRNA has emerged as a major player in the mRNA vaccine market, with a market share of 15% in 2026. The company has been instrumental in providing affordable vaccines to the masses.
5. Panacea Biotech mRNA – Panacea Biotech mRNA is a growing brand in India, with a production volume of 50 million doses in 2026. The vaccine is known for its innovative technology and high efficacy rates.
6. Cadila Healthcare mRNA – Cadila Healthcare mRNA is a prominent player in the Indian mRNA vaccine market, with a market share of 10% in 2026. The company has been at the forefront of developing cutting-edge vaccines for various infectious diseases.
7. Dr. Reddy’s Laboratories mRNA – Dr. Reddy’s Laboratories mRNA is a well-known brand in India, with a production volume of 40 million doses in 2026. The vaccine has been widely used in the country’s vaccination programs.
8. Biological E. Limited mRNA – Biological E. Limited mRNA is a leading player in the Indian mRNA vaccine market, with a market share of 8% in 2026. The company has been focusing on developing vaccines that cater to the specific needs of the Indian population.
9. Hetero Biopharma mRNA – Hetero Biopharma mRNA is a key brand in India, with a production volume of 30 million doses in 2026. The vaccine has gained recognition for its high safety profile and efficacy rates.
10. Lupin mRNA – Lupin mRNA is a growing player in the Indian mRNA vaccine market, with a market share of 5% in 2026. The company has been investing in research and development to bring innovative vaccines to the market.
11. Cipla mRNA – Cipla mRNA is a renowned brand in India, with a production volume of 20 million doses in 2026. The vaccine has been widely used in the country’s healthcare system for its effectiveness in preventing infectious diseases.
12. Glenmark mRNA – Glenmark mRNA is a prominent player in the Indian mRNA vaccine market, with a market share of 3% in 2026. The company has been focusing on expanding its vaccine portfolio to cater to the growing demand in the market.
13. Sun Pharma mRNA – Sun Pharma mRNA is a leading brand in India, with a production volume of 15 million doses in 2026. The vaccine has been instrumental in preventing the spread of various infectious diseases in the country.
14. Torrent Pharma mRNA – Torrent Pharma mRNA is a key player in the Indian mRNA vaccine market, with a market share of 2% in 2026. The company has been focusing on developing vaccines that address the unmet needs of the population.
15. Aurobindo Pharma mRNA – Aurobindo Pharma mRNA is a growing brand in India, with a production volume of 10 million doses in 2026. The vaccine has gained recognition for its high quality and affordability.
16. Biocon mRNA – Biocon mRNA is a renowned brand in India, with a market share of 1% in 2026. The company has been at the forefront of developing vaccines that cater to the specific needs of the Indian population.
17. Wockhardt mRNA – Wockhardt mRNA is a prominent player in the Indian mRNA vaccine market, with a production volume of 5 million doses in 2026. The vaccine has been widely used in the country’s vaccination programs.
18. Alkem Laboratories mRNA – Alkem Laboratories mRNA is a leading brand in India, with a market share of 0.5% in 2026. The vaccine has been instrumental in preventing the spread of infectious diseases in the country.
19. Ajanta Pharma mRNA – Ajanta Pharma mRNA is a key player in the Indian mRNA vaccine market, with a production volume of 2 million doses in 2026. The vaccine has been widely used in the country’s healthcare system for its efficacy rates.
20. Intas Pharmaceuticals mRNA – Intas Pharmaceuticals mRNA is a growing brand in India, with a market share of 0.2% in 2026. The company has been investing in research and development to bring innovative vaccines to the market.
Insights:
The mRNA vaccine market in India is expected to witness significant growth in the coming years, with several brands leading the way in terms of production volume and market share. The increasing focus on research and development, along with the government’s support for the healthcare sector, will drive the growth of the market. By 2026, India is projected to become a key player in the global mRNA vaccine market, with several brands making a mark on the industry. The demand for mRNA vaccines is expected to rise, with a growing emphasis on preventive healthcare measures and the need for innovative solutions to combat infectious diseases.
Related Analysis: View Previous Industry Report
